Kronik myeloproliferatif neoplazm ve subklinik hipotiroidizm ile ilişkili akut portal ven trombozu
Öz
-
Anahtar Kelimeler
Kaynakça
- Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-70.
- DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-64.
- Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol. 2013;162:730-47.
- Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-61.
- Scott LM, Scott MA, Campbell PJ, Green AR. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood. 2006;108:2435-7.
- Cheung B, Radia D, Pantelidis P, Yadegarfar G, Harrison C. The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia. Br J Haematol. 2006;132:244-5.
- Squizzato A, Romualdi E, Piantanida E, Gerdes VE, Büller HR, Tanda M et al. Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost. 2007;97(5):803-6.
- Hostiuc M, Curca GC, Dermengiu D, Sinescu C, Hostiuc S. Can subclinical hypothyroidism explain some sudden deaths due to pulmonary embolism without evident risk factors? Med Hypotheses. 2011;76:855-7.
- Hostiuc S, Capatina CO, Sinescu CJ, Hostiuc M. Lethal pulmonary thromboembolism associated with decreased thyroid hormone levels. Arch Endocrinol Metab. 2015;59:355-8.
- Segna D, Méan M, Limacher A, Baumgartner C, Blum MR, Beer JH et al. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study. J Thromb Haemost. 2016;14:685-94.
